Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.7.6 (
RNA polymerase
)
34,946
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In mammalian
RNA polymerase I
transcription, SL1, an assembly of TBP and associated factors (TAFs), is essential for preinitiation complex formation at ribosomal RNA gene promoters in vitro. We provide evidence for a novel component of SL1,
TAF(I)41
(
MGC5306
), which functions in Pol I transcription.
TAF(I)41
resides at the rDNA promoter in the nucleolus and co-purifies and co-immunoprecipitates with SL1.
TAF(I)41
immunodepletion from nuclear extracts dramatically reduces Pol I transcription; addition of SL1 restores the ability of these extracts to support Pol I transcription. In cells, siRNA-mediated decreased expression of
TAF(I)41
leads to loss of SL1 from the rDNA promoter in vivo, with concomitant loss of Pol I from the rDNA and reduced synthesis of the pre-rRNA. Extracts from these cells support reduced levels of Pol I transcription; addition of SL1 to the extracts raises the level of Pol I transcription. These data suggest that
TAF(I)41
is integral to transcriptionally active SL1 and imply a role for SL1, including the
TAF(I)41
subunit, in Pol I recruitment and, therefore, preinitiation complex formation in vivo.
...
PMID:A novel TBP-associated factor of SL1 functions in RNA polymerase I transcription. 1731 77